The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Tuberculosis is responsible for one in four of all avoidable adult deaths in developing countries. Increased frequency and accelerated fatality of the disease among individuals infected with human immunodeficiency virus has raised worldwide concern that control programmes may be inadequate, and the emergence of multidrug-resistant strains of Mycobacterium tuberculosis has resulted in several recent fatal outbreaks in the United States. Isonicotinic acid hydrazide (isoniazid, INH) forms the core of antituberculosis regimens; however, clinical isolates that are resistant to INH show reduced catalase activity and a relative lack of virulence in guinea-pigs. Here we use mycobacterial genetics to study the molecular basis of INH resistance. A single M. tuberculosis gene, katG, encoding both catalase and peroxidase, restored sensitivity to INH in a resistant mutant of Mycobacterium smegmatis, and conferred INH susceptibility in some strains of Escherichia coli. Deletion of katG from the chromosome was associated with INH resistance in two patient isolates of M. tuberculosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An INH-resistant strain of mc2155 was shown to become sensitive upon expression of the M. tuberculosis catalase-peroxidase gene, katG, suggesting that susceptibility to INH requires the expression of katG (127).”
From Mycobacterium smegmatis: The Vanguard of Mycobacterial Research (2023) · cites this paper as [127]
Citations
Cites
Snapper, S. B., Melton, R. E., Mustafa, S., Kieser, T., & Jr, W. R. J. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb02040.x · Cited by 1,237
Snider, D. E., & Roper, W. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203053261011 · Cited by 382
Lysogeny and transformation in mycobacteria: stable expression of foreign genes.
Snapper, S. B., Lugosi, L., Jekkel, A., Melton, R. E., Kieser, T., Bloom, B. R., & Jacobs, W. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6987 · Cited by 326
The Biology of the Mycobacteria
Ratledge, C., & Stanford, J. L. (1982) · Cited by 254
Genetic analysis of superoxide dismutase, the 23 kilodalton antigen of Mycobacterium tuberculosis
Zhang, Y., Lathigra, R., Garbe, T., Catty, D., & Young, D. (1991) · Molecular Microbiology · doi:10.1111/j.1365-2958.1991.tb02120.x · Cited by 182
Self-citationWayne, L. G., & Diaz, G. A. (1986) · Analytical Biochemistry · doi:10.1016/0003-2697(86)90200-9 · Cited by 173
Perriëns, J. H., Colebunders, R. L., Karahunga, C., Willame, J.-C., Jeugmans, J., Kaboto, M., Mukadi, Y., Pauwels, P., Ryder, R. W., Prignot, J., et al. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.4.750 · Cited by 162
JACKETT, P. S., ABER, V. R., & LOWRIE, D. B. (1978) · Journal of General Microbiology · doi:10.1099/00221287-104-1-37 · Cited by 162
Nucleotide sequence of katG, encoding catalase HPI of Escherichia coli
Triggs‐Raine, B. L., Doble, B. W., Mulvey, M. R., Sorby, P. A., & Loewen, P. C. (1988) · Journal of Bacteriology · doi:10.1128/jb.170.9.4415-4419.1988 · Cited by 139
Mulvey, M. R., Sorby, P. A., Triggs‐Raine, B. L., & Loewen, P. C. (1988) · Gene · doi:10.1016/0378-1119(88)90498-2 · Cited by 121
Research works printed but not linked: 4
- Murray, C. J. L., Styblo, K. & Rouillon, A. Bull. Int. Union against Tuberculosis and Lung Disorders 65, 6–24 (1990).
- Cohn, M. L., Kovitz, C., Oda, U. & Middlebrook, G. Am. Rev. Tuberc. 70, 641–664 (1954).
- Youatt, J. Am. Rev. respir. Dis. 99, 729–749 (1969).
- Heym, B. & Cole, S. T. Res. Microbiol. (in the press).
Cited by
Items 601–700 of 1,000
Modeling of Mycobacterium tuberculosis dormancy in bacterial cultures
Batyrshina, Y., & Schwartz, Y. S. (2019) · Tuberculosis · doi:10.1016/j.tube.2019.05.005 · Cited by 29
Adduct Formation of Delamanid with NAD in Mycobacteria
Hayashi, M., Nishiyama, A., Kitamoto, R., Tateishi, Y., Osada‐Oka, M., Nishiuchi, Y., Kaboso, S. A., Chen, X., Fujiwara, M., Inoue, Y., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01755-19 · Cited by 27
Novel Isoniazid-Carborane Hybrids Active In Vitro against Mycobacterium tuberculosis
Różycka, D., Korycka‐Machała, M., Żaczek, A., Dziadek, J., Gurda, D., Orlicka-Płocka, M., Wyszko, E., Biniek-Antosiak, K., Rypniewski, W. R., & Olejniczak, A. B. (2020) · Pharmaceuticals · doi:10.3390/ph13120465 · Cited by 27
Gold nanoprobes for multi loci assessment of multi-drug resistant tuberculosis
Pedrosa, P., Veigas, B., Machado, D., Couto, I., Viveiros, M., & Baptista, P. V. (2014) · Tuberculosis · doi:10.1016/j.tube.2013.12.009 · Cited by 27
Detecting Novel Genetic Variants Associated with Isoniazid-Resistant Mycobacterium tuberculosis
Shekar, S., Yeo, Z. X., Wong, J. C. L., Chan, M., Ong, D. C. T., Tongyoo, P., Wong, S. Y., & Lee, A. S. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102383 · Cited by 27
Isoniazid: Radical-induced oxidation and reduction chemistry
Rickman, K. A., Swancutt, K. L., Mezyk, S. P., & Kiddle, J. J. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.006 · Cited by 27
Effect of efflux pump inhibitors on the susceptibility of Mycobacterium tuberculosis to isoniazid
Jaiswal, I., Jain, A., Verma, S., Singh, P., Kant, S., & Singh, M. (2017) · Lung India · doi:10.4103/0970-2113.217567 · Cited by 27
Mycolic Acids: From Chemistry to Biology
Daffé, M., Quémard, A., & Marrakchi, H. (2017) · Springer eBooks · doi:10.1007/978-3-319-43676-0_18-1 · Cited by 34
Wheeler, P. R., & ANDERSON, P. M. (1996) · Biochemical Journal · doi:10.1042/bj3180451 · Cited by 27
Exploring the Structure and Function of the Mycobacterial KatG Protein Using trans -Dominant Mutants
DeVito, J. A., & Morris, S. L. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.188-195.2003 · Cited by 27
Broussy, S., Coppel, Y., Nguyen, M., Bernadou, J., & Meunier, B. (2003) · Chemistry - A European Journal · doi:10.1002/chem.200204637 · Cited by 27
The Mycobacterial Cell Envelope
Besra, G. S., & Brennan, P. J. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06146.x · Cited by 34
Efficacy and Mode of Action of a Direct Inhibitor of Mycobacterium abscessus InhA
Alcaraz, M., Roquet, F., Leon‐Icaza, S. A., Abendroth, J. A., Boudehen, Y., Cougoule, C., Edwards, T. E., & Kremer, L. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00314 · Cited by 29
Unissa, A. N., Selvakumar, N., Narayanan, S., Suganthi, C., & Hanna, L. E. (2015) · BioMed Research International · doi:10.1155/2015/257983 · Cited by 26
Siu, G. G., Yam, W. C., Zhang, Y., & Kao, R. Y. T. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03277-14 · Cited by 31
Self-citationRani, A., Johansen, M. D., Roquet, F., Kremer, L., Awolade, P., Ebenezer, O., Singh, P., Sumanjit, & Kumar, V. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127576 · Cited by 26
Diagnosis of cutaneous tuberculosis in biopsy specimens by PCR and southern blotting.
Quirós, E., Maroto, M. C., Bettinardi, A., González, I., & Piedrola, G. (1996) · Journal of Clinical Pathology · doi:10.1136/jcp.49.11.889 · Cited by 26
Zhang, Z., Sun, Z.-Q., Wang, Z.-L., Hu, H., Wen, Z., Song, Y., Zhao, J., Wang, H.-H., Guo, X., & Zhang, S.-L. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03818.x · Cited by 27
Otsuka, Y., Parniewski, P., Zwolska, Z., Kai, M., Fujino, T., Kirikae, F., Toyota, E., Kudo, K., Kuratsuji, T., & Kirikae, T. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.8.3538-3548.2004 · Cited by 26
Evidence for Radical Formation at Tyr-353 in Mycobacterium tuberculosis Catalase-Peroxidase (KatG)
Zhao, X., Girotto, S., Yu, S., & Magliozzo, R. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311884200 · Cited by 26
Ausina, V., Riutort, N., Viñado, B., Manterola, J. M., Manzano, J. R., Rodrigo, C., Matas, L., Giménez, M., Tor, J., & Roca, J. (1995) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02111867 · Cited by 26
The kinetic properties producing the perfunctory pH profiles of catalase-peroxidases
Moore, R. L., Powell, L. J., & Goodwin, D. C. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.03.008 · Cited by 25
Nakanaga, K., Hoshino, Y., Yotsu, R. R., Makino, M., & Ishii, N. (2012) · The Journal of Dermatology · doi:10.1111/1346-8138.12047 · Cited by 28
A High Dose of Isoniazid Disturbs Endobiotic Homeostasis in Mouse Liver
Li, F., Wang, P., Liu, K., Tarragó, M. G., Lu, J. L., Chini, E. N., & Ma, X. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.070920 · Cited by 25
Modi, P., Patel, S. P., & Chhabria, M. T. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1465852 · Cited by 25
Zhao, X., Yu, S., Ranguelova, K., Suárez, J., Metlitsky, L., Schelvis, J. P. M., & Magliozzo, R. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808107200 · Cited by 25
Multidrug-resistant tuberculosis
Lemos, A. C. M., & Matos, E. D. (2013) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2013.01.007 · Cited by 39
Mechanisms of Action and Resistance of Antimycobacterial Agents
Karakousis, P. C. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-180-2_24 · Cited by 31
Grassi, C. (1997) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.6.9.1211 · Cited by 26
Rotta, M., Pissinate, K., Villela, A. D., Back, D. F., Timmers, L. F. S. M., Bachega, J. F. R., de Souza, O. N., Santos, D. S., Basso, L. A., & Machado, P. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.11.034 · Cited by 24
Deraeve, C., Dorobantu, I.-M., Rebbah, F., Quéméner, F. L., Constant, P., Quémard, A., Bernardes‐Génisson, V., Bernadou, J., & Pratviel, G. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.09.017 · Cited by 24
Regmi, S. M., Chaiprasert, A., Kulawonganunchai, S., Tongsima, S., Coker, O. O., Prammananan, T., Viratyosin, W., & Thaipisuttikul, I. (2015) · Molecular Genetics and Genomics · doi:10.1007/s00438-015-1048-0 · Cited by 27
Zarafu, I., Matei, L., Bleoţu, C., Ioniță, P., Tatibouët, A., Păun, A., Nicolau, I. A., Hanganu, A., Limban, C., Nuță, D. C., et al. (2020) · Molecules · doi:10.3390/molecules25143308 · Cited by 24
Ma, S., Morrison, R., Hobbs, S. J., Soni, V., Farrow-Johnson, J., Frando, A., Fleck, N. D., Grundner, C., Rhee, K. Y., Rustad, T. R., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00810-x · Cited by 25
Stigliani, J., Arnaud, P., Delaine, T., Bernardes‐Génisson, V., Meunier, B., & Bernadou, J. (2008) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2008.09.006 · Cited by 24
The katE gene, which encodes the catalase HPII of Mycobacterium avium
Milano, A., Rossi, E. D., Gusberti, L., Heym, B., Marone, P., & Riccardi, G. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.352876.x · Cited by 24
Self-citationHerrera, L., Valverde, A., Sáiz, P. A., Sáez-Nieto, J. A., Portero, J. L., & Jiménez, M. S. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.09.032 · Cited by 23
Wengenack, N. L., Lane, B. D., Hill, P. J., Uhl, J. R., Lukat-Rodgers, G. S., Hall, L., Roberts, G. D., Cockerill, F. R., Brennan, P. J., Rodgers, K. R., et al. (2004) · Protein Expression and Purification · doi:10.1016/j.pep.2004.04.018 · Cited by 23
Multidrug-resistant Tuberculosis (MDRTB)
Spradling, P. R., & Ridzon, R. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-48411-0_7 · Cited by 23
Pattern of InhA and KatG mutations in isoniazid monoresistant Mycobacterium tuberculosis isolates
Gupta, N., Charan, A., Dixit, R., Arora, P., Patni, T., Antony, K., & Singh, M. (2020) · Lung India · doi:10.4103/lungindia.lungindia_204_19 · Cited by 23
Johansen, M. D., Shalini, S., Kumar, S., Raynaud, C., Quan, D. H., Britton, W. J., Hansbro, P. M., Kumar, V., & Kremer, L. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00011-21 · Cited by 24
Lu, X., Chen, Y., Jiang, Y., & You, Q. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.03.043 · Cited by 23
Synthesis and bioevaluation of some new isoniazid derivatives
Matei, L., Bleoţu, C., Baciu, I., Drăghici, C., Ioniță, P., Păun, A., Chifiriuc, M. C., Sbarcea, A., & Zarafu, I. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.06.013 · Cited by 23
Lucana, D. O. D. O., Tröller, M., & Schrempf, H. (2003) · Molecular Genetics and Genomics · doi:10.1007/s00438-002-0776-0 · Cited by 23
Georgieva, N. V., & Gadjeva, V. G. (2002) · Biochemistry (Moscow) · doi:10.1023/a:1015558514432 · Cited by 25
Muccio, D. D., Brouillette, W. J., Alam, M., Vaezi, M. F., Sani, B. P., Venepally, P., Reddy, L. G., Li, E., Norris, A. W., Simpson‐Herren, L., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9603126 · Cited by 23
Domenech, P., Honoré, N., Heym, B., & Cole, S. T. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01422-8 · Cited by 25
Self-citationRegulation of virulence genes in Mycobacterium tuberculosis
Mehrotra, J., & Bishai, W. R. (2001) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00113 · Cited by 26
Nucleotide sequence of the Mycobacterium leprae katG region
Nakata, N., Matsuoka, M., Kashiwabara, Y., Okada, N., & Sasakawa, C. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.9.3053-3057.1997 · Cited by 23
An Epitope Delivery System for Use with Recombinant Mycobacteria
Hetzel, C., Janssen, R., Ely, S. J., Kristensen, N. M., Bunting, K. A., Cooper, J. B., Lamb, J. R., Young, D. B., & Thole, J. E. R. (1998) · Infection and Immunity · doi:10.1128/iai.66.8.3643-3648.1998 · Cited by 23
Self-citationSingh, A. P., Singh, A. P., Grover, S., Pandey, B., Kumari, A., & Grover, A. (2017) · Gene · doi:10.1016/j.gene.2017.10.047 · Cited by 22
Differential Expression of Resistant and Efflux Pump Genes in MDR-TB Isolates
AlMatar, M., Var, İ., Kayar, B., & Köksal, F. (2019) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530319666191009153834 · Cited by 26
Engström, A. (2015) · Scandinavian Journal of Infectious Diseases · doi:10.3109/23744235.2015.1061205 · Cited by 25
Sellar-Suprasellar Tuberculomas in Children: 2 Cases and Literature Review
Nayil, K., Singh, S., Makhdoomi, R. H., Ramzan, A., & Wani, A. A. (2011) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2011.01.020 · Cited by 22
Gomez, A., Andreu, N., Ferrer‐Navarro, M., Yero, D., & Gibert, I. (2016) · Scientific Reports · doi:10.1038/srep26221 · Cited by 22
Hydroxylation of Antitubercular Drug Candidate, SQ109, by Mycobacterial Cytochrome P450
Bukhdruker, S. S., Varaksa, T., Grabovec, I. P., Marin, E., Shabunya, P., Kadukova, M., Grudinin, S., Kavaleuski, A., Gusach, A., Gilep, A. A., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207683 · Cited by 22
Lucana, D. O. D. O., Bogel, G., Zou, P., & Groves, M. R. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.01.017 · Cited by 22
Unusual post-translational protein modifications: the benefits of sophistication
Ravikiran, B., & Mahalakshmi, R. (2014) · RSC Advances · doi:10.1039/c4ra04694c · Cited by 22
Saharan, V. D., & Mahajan, S. S. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.01.026 · Cited by 23
Jagadeb, M., Rath, S. N., & Sonawane, A. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1515116 · Cited by 22
dos Santos, F. D. J. N., Ximenes, V. F., da Fonseca, L. M., Oliveira, O. M. M. D. F., & Brunetti, I. L. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.1822 · Cited by 22
Regelsberger, G., Obinger, C., Zoder, R., Altmann, F., & Peschek, G. A. (1999) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1999.tb13348.x · Cited by 22
Maslow, J. N., Irani, V. R., Lee, S.-H., Eckstein, T. M., Inamine, J. M., & Belisle, J. T. (2003) · Microbiology · doi:10.1099/mic.0.26565-0 · Cited by 22
Catalase–peroxidase activity has no influence on virulence in a murine model of tuberculosis
Cardona, P.-J., Gordillo, S., Amat, I., Díaz, J., Lonca, J., Vilaplana, C., Pallarés, Á., Llatjós, R., Ariza, A., & Ausina, V. (2003) · Tuberculosis · doi:10.1016/s1472-9792(03)00056-8 · Cited by 22
Antimycobacterial susceptibility testing: Present practices and future trends
Inderlied, C. B. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02111499 · Cited by 22
Wondale, B., Medhin, G., Abebe, G., Tolosa, S., Mohammed, T., Teklu, T., Pieper, R., & Ameni, G. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s165088 · Cited by 27
Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis in Mongolia
Narmandakh, E., Tumenbayar, O., Borolzoi, T., Erkhembayar, B., Boldoo, T., Dambaa, N., Burneebaatar, B., Naranbat, N., Mitarai, S., Jav, S., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00537-20 · Cited by 21
Rossini, N. D. O., & Dias, M. V. B. (2023) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2022-0261 · Cited by 25
In vitro toxic action potential of anti tuberculosis drugs and their combinations
Fatima, R. A., Ashraf, M. A., Ejaz, S., Rasheed, M. A., Altaf, I., Afzal, M., Batool, Z., Saleem, U., & Anwar, K. (2013) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2013.05.008 · Cited by 21
Drug targeting of heme proteins in Mycobacterium tuberculosis
McLean, K. J., & Munro, A. W. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.11.004 · Cited by 21
Mycolic Acids: From Chemistry to Biology
Daffé, M., Quémard, A., & Marrakchi, H. (2019) · Springer eBooks · doi:10.1007/978-3-319-50430-8_18 · Cited by 24
Horváti, K., Fodor, K., Pályi, B., Henczkó, J., Balka, G., Gyulai, G., Kiss, É., Biri‐Kovács, B., Senoner, Z., & Bősze, S. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.750496 · Cited by 21
Hoeksema, M., Jonker, M. J., Bel, K., Brul, S., & ter Kuile, B. H. (2018) · BMC Genomics · doi:10.1186/s12864-018-5353-y · Cited by 23
Molecular biology in the diagnosis and epidemiology of tuberculosis
Drobniewski, F. A., Kent, R., Stoker, N. G., & Uttley, A. H. C. (1994) · Journal of Hospital Infection · doi:10.1016/0195-6701(94)90089-2 · Cited by 24
Expression of Foreign Genes in Mycobacteria
Burlein, J. E., Stover, C. K., Offutt, S., & Hanson, M. S. (2014) · ASM Press eBooks · doi:10.1128/9781555818357.ch17 · Cited by 21
New potential drug leads against MDR-MTB: A short review
Gatadi, S., & Nanduri, S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103534 · Cited by 20
How Mycobacterium tuberculosis drug resistance has shaped anti-tubercular drug discovery
Bhagwat, A., Deshpande, A., & Parish, T. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.974101 · Cited by 20
Interactions of isoniazid with membrane models: Implications for drug mechanism of action
Pinheiro, M., Silva, A. S., Pisco, S., & Reis, S. (2014) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2014.07.002 · Cited by 20
Resistencia a los antimicrobianos y virulencia bacteriana
Linares-Rodríguez, J. F., & Martínez, J. L. (2005) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13071612 · Cited by 38
Kumar, P., Kumar, P., Balooni, V., & Singh, S. (2015) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.14.0596 · Cited by 20
Insights on the Mechanism of Action of INH-C 10 as an Antitubercular Prodrug
Vila‐Viçosa, D., Victor, B. L., Ramos, J., Machado, D., Viveiros, M., Switala, J., Loewen, P. C., Elvas‐Leitão, R., Martins, F. E. L., & Machuqueiro, M. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00719 · Cited by 20
The Evolution of Antibiotic Resistance
Gónzález‐Candelas, F., Comas, I., Martínez, J. L., Galán, J. C., & Baquero, F. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-384890-1.00012-1 · Cited by 26
Yimcharoen, M., Saikaew, S., Wattananandkul, U., Phunpae, P., Intorasoot, S., Kasinrerk, W., Tayapiwatana, C., & Butr-indr, B. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s346869 · Cited by 20
Five-antituberculosis Drug-resistance Genes Detection Using Array System
Shimizu, Y., Dobashi, K., Yoshikawa, Y., YABE, S., Higuchi, S., Koike, Y., Mita, Y., Utsugi, M., Endou, K., Takahashi, K., et al. (2008) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.2008033 · Cited by 22
Joshi, S. D., More, U. A., Koli, D., Kulkarni, M. S., Nadagouda, M. N., & Aminabhavi, T. M. (2015) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2015.03.001 · Cited by 20
Koshkin, A., Zhou, X.-T., Kraus, C. N., Brenner, J. M., Bandyopadhyay, P., Kuntz, I. D., Barry, C. E., & de Montellano, P. R. O. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2424-2430.2004 · Cited by 20
Zewdie, O., Mihret, A., Abebe, T., Kebede, A., Desta, K., Worku, A., & Ameni, G. (2017) · New Microbes and New Infections · doi:10.1016/j.nmni.2017.10.009 · Cited by 20
Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis
Ahmad, S., & Mokaddas, E. M. (2010) · Respiratory Medicine CME · doi:10.1016/j.rmedc.2010.08.001 · Cited by 20
Origen, presente y futuro de las resistencias en tuberculosis
Luna, J. A. C. (2001) · Archivos de Bronconeumología · doi:10.1016/s0300-2896(01)75005-3 · Cited by 33
Ferrazoli, L., Palaci, M., Telles, M. A. D. S., Ueki, S. Y. M., Kritski, A. L., Marques, L. R. M., Ferreira, O. C., & Riley, L. W. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.1.237 · Cited by 20
Genetic basis of isoniazid resistance of Mycobacterium tuberculosis
Zhang, Y. (1993) · Research in Microbiology · doi:10.1016/0923-2508(93)90029-2 · Cited by 20
Self-citationFilling the Pipeline - New Drugs for an Old Disease
Stehr, M., Elamin, A. A., & Singh, M. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026613666131113152908 · Cited by 28
Metals and Metal Oxides: Important Nanomaterials With Antimicrobial Activity
Khan, S. T., & Al-Khedhairy, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-52733-0.00008-2 · Cited by 24
Advances in the development of molecular genetic tools for Mycobacterium tuberculosis
Chhotaray, C., Tan, Y., Mugweru, J., Islam, M. M., Hameed, H. M. A., Wang, S., Lu, Z., Wang, C., Li, X., Tan, S., et al. (2018) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2018.06.003 · Cited by 20
Genetics and roadblocks of drug resistant tuberculosis
Perdigão, J., & Portugal, I. (2018) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2018.09.023 · Cited by 19
Chapter 8: Drug-resistant tuberculosis
Brode, S. K., Dwilow, R., Kunimoto, D. Y., Menzies, D., & Khan, F. A. (2022) · Canadian Journal of Respiratory Critical Care and Sleep Medicine · doi:10.1080/24745332.2022.2039499 · Cited by 27
de la Iglesia, A. I., & Morbidoni, H. R. (2006) · PubMed · Cited by 29
Ali, A., Hasan, Z., Moatter, T., Tanveer, M., & Hasan, R. (2008) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540802570519 · Cited by 19
Vital roles of an interhelical insertion in catalase?peroxidase bifunctionality*1, *2
Li, Y., & Goodwin, D. C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.130 · Cited by 19
Isoniazid, The Frontline of Resistance in Mycobacterium tuberculosis
Whitney, J. B., & Wainberg, M. A. (2002) · McGill Journal of Medicine · doi:10.26443/mjm.v6i2.686 · Cited by 19
Metadata
- Authors
- Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S.
- Affiliations
- Hammersmith Hospital (GB)
- Institut Pasteur (FR)
- Venue
- Nature
- Published
- 1992-08-13
- Volume
- 358
- Issue
- 6387
- Pages
- 591-593
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2058925610
- Cited by
- 1,299
- References
- 17
- Citations by year
- 2026: 21 · 2025: 27 · 2024: 28 · 2023: 26 · 2022: 35 · 2021: 34 · 2020: 47 · 2019: 45 · 2018: 49 · 2017: 50 · 2016: 36 · 2015: 47 · 2014: 69 · 2013: 37 · 2012: 50
- FWCI
- 37.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Keywords
- isoniazid resistance, Mycobacterium tuberculosis, katG gene, catalase-peroxidase, multidrug resistance, Mycobacterium smegmatis, Escherichia coli, gene deletion, antitubercular agents, tuberculosis
- MeSH terms
- Amino Acid Sequence, Bacterial Proteins, Base Sequence, Catalase, Cloning, Molecular, DNA, Bacterial, Drug Resistance, Microbial, Escherichia coli, Genes, Bacterial, Isoniazid, Molecular Sequence Data, Mutation, Mycobacterium tuberculosis, Peroxidases, Plasmids, Blotting, Southern, Restriction Mapping, Oligonucleotide Probes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.